Cargando…
Radionuclide (131)I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer
OBJECTIVES: Anaplastic thyroid cancer (ATC) cells cannot retain the radionuclide iodine 131 ((131)I) for treatment due to the inability to uptake iodine. This study investigated the feasibility of combining radionuclides with photothermal agents in the diagnosis and treatment of ATC. METHODS: (131)I...
Autores principales: | Zhang, Xuemei, Yan, Ziyu, Meng, Zhaowei, Li, Ning, Jia, Qiang, Shen, Yiming, Ji, Yanhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358776/ https://www.ncbi.nlm.nih.gov/pubmed/35957867 http://dx.doi.org/10.3389/fonc.2022.889284 |
Ejemplares similares
-
Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer
por: Tian, Longlong, et al.
Publicado: (2017) -
HSA-MnO(2)-(131)I Combined Imaging and Treatment of Anaplastic Thyroid Carcinoma
por: Yan, Ziyu, et al.
Publicado: (2022) -
Rationally assembled albumin/indocyanine green nanocomplex for enhanced tumor imaging to guide photothermal therapy
por: An, Feifei, et al.
Publicado: (2020) -
Indocyanine Green-Loaded Halloysite Nanotubes as Photothermal
Agents
por: Demirel, Oyku, et al.
Publicado: (2023) -
Synergistic chemo-/photothermal therapy based on supercritical technology-assisted chitosan–indocyanine green/luteolin nanocomposites for wound healing
por: Xu, Pei-Yao, et al.
Publicado: (2022)